Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florent Guerin

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Medicine|November 29, 2024
Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor CommitteeFrançois Sevrin, Emilie Bogart, Daniel Orbach, et al.
Cancer Medicine|February 23, 2020
Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committeeThibault Butel, Marie Karanian, Gaelle Pierron, et al.
Annals of Surgical Oncology|September 2, 2024
Laparoscopic Treatment of Wilms' Tumor: Criteria of SIOP-UMBRELLA Protocol may be UpdatedMorgan Pradier, Sabine Irtan, Hubert Ducou Le Pointe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2025
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European <i>Paediatric</i> Soft Tissue Sarcoma Study Group RMS 2005 TrialGianni Bisogno, Julia Chisholm, Raquel Hladun, et al.
Orphanet Journal of Rare Diseases|July 19, 2022
International registry of congenital porto-systemic shunts: a multi-centre, retrospective and prospective registry of neonates, children and adults with congenital porto-systemic shuntsSimona Korff, Khaled Mostaguir, Maurice Beghetti, et al.
Cancer|February 24, 2024
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogramGian Luca De Salvo, Paola Del Bianco, Veronique Minard-Colin, et al.
Cancers|January 21, 2023
Developments in the Surgical Approach to Staging and Resection of RhabdomyosarcomaSheila Terwisscha van Scheltinga, Timothy Rogers, Naima Smeulders, et al.
Cancer|May 28, 2025
Impact of maintenance treatment on male gonadal function in patients treated for localized rhabdomyosarcoma in RMS2005 trial in FranceLea Rossillon, Cécile Thomas-Teinturier, Daniel Orbach, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2024
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survivalAurore Pire, Theo Z Hirsch, Guillaume Morcrette, et al.
Cancer Discovery|April 24, 2021
Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver CancerTheo Z Hirsch, Jill Pilet, Guillaume Morcrette, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Medicine|November 29, 2024
Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor CommitteeFrançois Sevrin, Emilie Bogart, Daniel Orbach, et al.
Cancer Medicine|February 23, 2020
Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committeeThibault Butel, Marie Karanian, Gaelle Pierron, et al.
Annals of Surgical Oncology|September 2, 2024
Laparoscopic Treatment of Wilms' Tumor: Criteria of SIOP-UMBRELLA Protocol may be UpdatedMorgan Pradier, Sabine Irtan, Hubert Ducou Le Pointe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2025
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European <i>Paediatric</i> Soft Tissue Sarcoma Study Group RMS 2005 TrialGianni Bisogno, Julia Chisholm, Raquel Hladun, et al.
Orphanet Journal of Rare Diseases|July 19, 2022
International registry of congenital porto-systemic shunts: a multi-centre, retrospective and prospective registry of neonates, children and adults with congenital porto-systemic shuntsSimona Korff, Khaled Mostaguir, Maurice Beghetti, et al.
Cancer|February 24, 2024
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogramGian Luca De Salvo, Paola Del Bianco, Veronique Minard-Colin, et al.
Cancers|January 21, 2023
Developments in the Surgical Approach to Staging and Resection of RhabdomyosarcomaSheila Terwisscha van Scheltinga, Timothy Rogers, Naima Smeulders, et al.
Cancer|May 28, 2025
Impact of maintenance treatment on male gonadal function in patients treated for localized rhabdomyosarcoma in RMS2005 trial in FranceLea Rossillon, Cécile Thomas-Teinturier, Daniel Orbach, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2024
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survivalAurore Pire, Theo Z Hirsch, Guillaume Morcrette, et al.
Cancer Discovery|April 24, 2021
Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver CancerTheo Z Hirsch, Jill Pilet, Guillaume Morcrette, et al.
Pageof 4